Dr. Ravi S. Marfatia, MD

Dr. Marfatia practices at Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority.

Dr. Marfatia's NPI, 1811196405, was assigned on July 13, 2007. Dr. Marfatia holds Colorado license DR.0065839.

Dr. Marfatia's primary practice is Denver Health Medical Center, at 777 Bannock St, Denver, CO 80204 in Denver County. The practice phone is (303) 602-4935.

Dr. Marfatia's primary practice is Denver Health Medical Center in Denver, Colorado, part of Denver Health and Hospital Authority. The medical group on file is Denver Health. Dr. Marfatia's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marfatia practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Marfatia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Marfatia's licenses on file in 2 states: Colorado and Georgia.

CMS data shows 486 Medicare services from Dr. Marfatia across 8 procedure codes in 2024, for 399 Medicare patients. Medicare paid $13,895 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 399 Medicare patients who saw Dr. Marfatia in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 55% have high cholesterol. 64% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marfatia's median patient age at 68, with 50% women.

In 2024, Dr. Marfatia wrote 544 Medicare Part D claims for 99 patients. 86% of them were for generic drugs. CMS names the drug for 430 of them, across 11 drugs with 11 or more claims each, at $24,540 in total drug cost. In 2023, CMS named 340 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Marfatia for performance year 2024, reported as part of a group. Dr. Marfatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Marfatia, published from 2010 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Hypertension and Apolipoproteins E. Dr. Marfatia has published most often in Arterioscler Thromb Vasc Biol. Dr. Marfatia's most frequent co-authors are Erick T. Avelar, MD, Simi Kumar and Albert J. Sinusas, MD.

CMS Open Payments shows 9 general payments to Dr. Marfatia from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Medtronic Vascular, Inc. paid the most, $338.